# OnCo record paper-prima-final-rituximab-maintenance-follicular-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-prima-final-rituximab-maintenance-follicular-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-prima-final-rituximab-maintenance-follicular-jco-2019" ;
  schema:name "Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study"@en ;
  schema:alternateName "PRIMA final analysis"@en, "Bachy 2019"@en ;
  schema:description "After nine years the antibody maintenance group had gone more than six years longer before their lymphoma returned, and exactly as many people in each group were alive."@en ;
  schema:url <https://onco.cc/key-papers/paper-prima-final-rituximab-maintenance-follicular-jco-2019/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.01073>, <https://pubmed.ncbi.nlm.nih.gov/31339826/>, <https://europepmc.org/article/MED/31339826> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.01073> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Bachy E, Seymour JF, Feugier P, et al." ;
  onco:related <https://onco.cc/key-papers/paper-prima-rituximab-maintenance-follicular-lancet-2011/>, <https://onco.cc/key-papers/paper-casulo-pod24-follicular-lymphoma-jco-2015/>, <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/lysa/> ;
  onco:terms <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/lymphoma-tx-maintenance/>, <https://onco.cc/terms/lymphoma-tx-pod24/> ;
  onco:trials <https://onco.cc/trials/prima-follicular/> ;
  onco:people <https://onco.cc/people/gilles-salles/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-patient-voice/> ;
  onco:journals <https://onco.cc/journals/jco/> .
